T cells

CAR-T cell therapy: a potential new strategy against prostate cancer
Giuseppe Schepisi, Maria Concetta Cursano, Chiara Casadei, Cecilia Menna, Amelia Altavilla, Cristian Lolli, Claudio Cerchione, Giovanni Paganelli, Daniele Santini, Giuseppe Tonini, Giovanni Martinelli, Ugo De Giorgi

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 258; DOI: 10.1186/s40425-019-0741-7
Characterization of the human T cell response to in vitro CD27 costimulation with varlilumab
Venky Ramakrishna, Karuna Sundarapandiyan, Biwei Zhao, Max Bylesjo, Henry C. Marsh, Tibor Keler

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (1) 37; DOI: 10.1186/s40425-015-0080-2
Combination immunotherapy: Where do we go from here?
Abigail E. Overacre, Sema Kurtulus, Mario Sznol, Drew M. Pardoll, Ana Anderson, Dario A. A. Vignali

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (1) 38; DOI: 10.1186/s40425-015-0083-z
Adjuvants for peptide-based cancer vaccines
Hiep Khong, Willem W. Overwijk

Journal for ImmunoTherapy of Cancer Dec 2016, 4 (1) 56; DOI: 10.1186/s40425-016-0160-y
Expansion of tumor-infiltrating lymphocytes (TIL) from human pancreatic tumors
MacLean Hall, Hao Liu, Mokenge Malafa, Barbara Centeno, Pamela J. Hodul, José Pimiento, Shari Pilon-Thomas, Amod A. Sarnaik

Journal for ImmunoTherapy of Cancer Dec 2016, 4 (1) 61; DOI: 10.1186/s40425-016-0164-7
Immunoregulatory functions of innate lymphoid cells
Sarah Q. Crome, Pamela S. Ohashi

Journal for ImmunoTherapy of Cancer Dec 2018, 6 (1) 121; DOI: 10.1186/s40425-018-0433-8
Soluble immune checkpoints in cancer: production, function and biological significance
Daqian Gu, Xiang Ao, Yu Yang, Zhuo Chen, Xiang Xu

Journal for ImmunoTherapy of Cancer Dec 2018, 6 (1) 132; DOI: 10.1186/s40425-018-0449-0
A systems biology approach to investigating the influence of exercise and fitness on the composition of leukocytes in peripheral blood
Michael P. Gustafson, Ara Celi DiCostanzo, Courtney M. Wheatley, Chul-Ho Kim, Svetlana Bornschlegl, Dennis A. Gastineau, Bruce D. Johnson, Allan B. Dietz

Journal for ImmunoTherapy of Cancer Dec 2017, 5 (1) 30; DOI: 10.1186/s40425-017-0231-8
Immunoglobulin-like transcript 2 (ILT2) is a biomarker of therapeutic response to oncolytic immunotherapy with vaccinia viruses
Andrew Zloza, Dae Won Kim, Seunghee Kim-Schulze, Michael C Jagoda, Vladia Monsurro, Francesco M Marincola, Howard L Kaufman

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 1; DOI: 10.1186/2051-1426-2-1
The histone deacetylase inhibitor, LBH589, promotes the systemic cytokine and effector responses of adoptively transferred CD8+ T cells
Dominique N Lisiero, Horacio Soto, Richard G Everson, Linda M Liau, Robert M Prins

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 8; DOI: 10.1186/2051-1426-2-8

Main menu

T cells

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

T cells

Pages